Ads
related to: next generation rna sequencing technology companies list in ohio state
Search results
Results from the WOW.Com Content Network
Schematic overview of the MERCURIUS BRB-seq workflow where up to 384 samples can be barcoded and multiplexed per kit.. Bulk RNA barcoding and sequencing (BRB-seq) is an ultra-high-throughput bulk 3' mRNA-seq technology that uses early-stage sample barcoding and unique molecular identifiers (UMIs) to allow the pooling of up to 384 samples in one tube early in the sequencing library preparation ...
As part of the Gene Alliance, founded in 1998, the company was involved in the large-scale genome analysis project Aspergillus niger funded by DSM (The Netherlands) and finished in 2001. [3] In 2006 the company started to develop the next generation sequencing business division adding the Europe's first commercial PacBio RS platform in 2011.
This design is very different from that of Sanger sequencing—also known as capillary sequencing or first-generation sequencing—which is based on electrophoretic separation of chain-termination products produced in individual sequencing reactions. [6] This methodology allows sequencing to be completed on a larger scale. [7]
New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. [2] It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. [3]
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and ...
RNA-Seq was first developed in mid 2000s with the advent of next-generation sequencing technology. [144] The first manuscripts that used RNA-Seq even without using the term includes those of prostate cancer cell lines [ 145 ] (dated 2006), Medicago truncatula [ 146 ] (2006), maize [ 147 ] (2007), and Arabidopsis thaliana [ 148 ] (2007), while ...
The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. [2] Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. [1]
Tempus AI, Inc. is an American health technology company [1] founded in 2015 by Eric Lefkofsky in Chicago, Illinois. [2] It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. [3]
Ads
related to: next generation rna sequencing technology companies list in ohio state